Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

BACKGROUND: The present study investigated the efficacy and safety of nivolumab in pre-treated patients with advanced NSCLC harbouring KRAS mutations. METHODS: Clinical data and KRAS mutational status were analysed in patients treated with nivolumab within the Italian Expanded Access Program. Object...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Passiglia, Francesco, Cappuzzo, Federico, Alabiso, Oscar, Bettini, Anna Cecilia, Bidoli, Paolo, Chiari, Rita, Defferrari, Carlotta, Delmonte, Angelo, Finocchiaro, Giovanna, Francini, Guido, Gelsomino, Francesco, Giannarelli, Diana, Giordano, Monica, Illiano, Alfonso, Livi, Lorenzo, Martelli, Olga, Natoli, Clara, Puppo, Gianfranco, Ricevuto, Enrico, Roca, Elisa, Turci, Daniele, Galetta, Domenico
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325128/
https://ncbi.nlm.nih.gov/pubmed/30377342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0234-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados